The advent of gene editingtechnologies further expands the possibilities for treating cardiovasculardisease by directly altering inflammation-related genes, such as TNF-α,to reduce cardiac inflammation and arrhythmia risk [103]. This evidence concerns the gene TNF and cardiac arrhythmia.